Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-15-000852
Filing Date
2015-03-12
Accepted
2015-03-12 12:04:28
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk1516398.htm 20-F 2465922
2 EXHIBIT 4.6 exhibit_4-6.htm EX-4.6 285059
3 EXHIBIT 8.1 exhibit_8-1.htm EX-8.1 2179
4 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 10914
5 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 10805
6 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 7370
7 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 4071
8 ey.jpg GRAPHIC 5215
  Complete submission text file 0001178913-15-000852.txt   12221406

Data Files

Seq Description Document Type Size
9 INSTANCE DOCUMENT cgen-20141231.xml EX-101.INS 1612187
10 TAXONOMY EXTENSION SCHEMA cgen-20141231.xsd EX-101.SCH 72343
11 TAXONOMY EXTENSION CALCULATION LINKBASE cgen-20141231_cal.xml EX-101.CAL 75490
12 TAXONOMY EXTENSION LABEL LINKBASE cgen-20141231_def.xml EX-101.DEF 280452
13 TAXONOMY EXTENSION PRESENTATION LINKBASE cgen-20141231_lab.xml EX-101.LAB 1127841
14 TAXONOMY EXTENSION DEFINITION LINKBASE cgen-20141231_pre.xml EX-101.PRE 524179
Mailing Address 72 PINCHAS ROSEN ST TEL AVIV L3 69512
Business Address 72 PINCHAS ROSEN ST TEL AVIV L3 69512 011-972-3-765-8585
COMPUGEN LTD (Filer) CIK: 0001119774 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-30902 | Film No.: 15695075
SIC: 2836 Biological Products, (No Diagnostic Substances)